Key points are not available for this paper at this time.
The growing burden of chronic kidney disease (CKD) places substantial financial pressures on patients, healthcare systems, and society. An understanding of the costs attributed to CKD and kidney replacement therapy (KRT) is essential for evidence-based policy making.
Chadban et al. (Thu,) studied this question.